DUBLIN--(BUSINESS WIRE)--Jul 30, 2020--

The "Cell and Gene Therapy Tools, and Reagents: Global Markets" report has been added to ResearchAndMarkets.com's offering.

Gene and cell therapy are emerging as important tools to treat human health. Techniques such as CAR-T therapy have emerged as key ways of treating many different types of cancers. The promise of gene therapy using technologies such as CRISPR is starting to be realized in clinical trials, and markets are scaling up to treat other diseases as well, particularly rare gene-based diseases. As these therapies are coming to the fore, a new market for tools to develop these therapies using standard methodologies is emerging. This report will cover what those tools are, how they impact the larger life science tools market, and how they will evolve over the next five years.

The scope of this study encompasses an investigation of the market's cell and gene therapy tools such as GMP proteins, media, cell separation and activation reagents, viral and non-viral, cytokine release syndrome monitoring products, GMP antibodies, leukapheresis instrumentation, immunoassays (multiplex and singleplex) and bioreactors. This research analyzes each tool type, determines its current market status, examines its impact on future markets, and presents forecasts of growth over the next five years. Technological issues, including the latest trends, are discussed. The report analyzes the industry on a worldwide basis, from both application and demand perspectives, in the major regions of the world.

The Report Includes:

  • 77 data tables
  • An overview of the global market for immunoassay-based cell and gene therapy tools, and reagents within the life sciences industry
  • Analyses of the global market trends, with data corresponding to market size for 2017-2019, and projections of compound annual growth rates (CAGRs) through 2024
  • Information about in-vitro diagnostics (IVD), its background and importance of IVD testing
  • Discussion on the prevalence of the infectious disease, metabolic disorders and chronic ailments as drivers of immunoassay testing market
  • Description of recent technologies such as chemiluminescent immunoassays (CLIA), fluorescent immunoassays, multiplex assays, and rapid diagnostic technologies
  • Evaluation of the market potential for immunoassay-based cell and gene therapy tools and reagents, current market size and market forecast, and market share analysis of the leading players engaged
  • Patent review and new developments, R&D efforts, industrial changes with emphasis on recent investments, and current state of the immunoassay technology
  • Company profiles of the key market participants, including Bio-Rad Laboratories, Cytiva Life Sciences, Luminex Corp., Millipore Sigma, Thermo Fisher Scientific and STEMCELL Technologies

Key Topics Covered:

Chapter 1 Introduction

  • Study Goals and Objectives
  • Reasons for Doing this Study
  • Scope of Report
  • Information Sources
  • Methodology
  • Geographic Breakdown

Chapter 2 Summary and Highlights

  • Evolution and Expansion of Therapies
  • Role for CRISPR?
  • New Vectors, New Solutions
  • Cell Therapy is Growing
  • Payor Policy Proves Potential
  • Coronavirus Crown?

Chapter 3 Market and Technology Background

  • Overview: Beginnings and Current State of Cell and Gene Therapy
  • Cell Therapy
  • Gene Therapy
  • Types of Cell and Gene Therapy
  • Gene Therapy
  • Cell Therapy
  • Common Equipment Used
  • Industry Structure
  • Major Companies and Market Share

Chapter 4 Market Breakdown by Region

  • Cell and Gene Therapy Equipment

Chapter 5 Market Breakdown by End User

Chapter 6 Government Regulations

  • Scope of Regulations on Gene Therapy
  • Viral and Non-Viral Vectors
  • Media
  • GMP Proteins and Antibodies
  • Cell Therapy
  • Leukapheresis
  • Cell Therapy, Gene Therapy and the EMA

Chapter 7 Patent Review/New Developments

  • Cell and Gene Therapy R&D
  • Academia
  • Industrial Changes
  • Recent Investments
  • Technology
  • Current State of Technology

Chapter 8 Analysis of Market Opportunities

  • Case Studies of Cell and Gene Therapy
  • Clinical Diagnostics
  • Pharmaceutical/Biotechnology

Chapter 9 Company Profiles

  • Abcam
  • Adverum Biotechnologies
  • Athersys Inc.
  • Avrobio
  • Bio-Rad Laboratories
  • Bio-Techne
  • Cellgenix
  • Cytiva Life Sciences
  • Luminex Corp.
  • Mesoblast Ltd.
  • Millipore Sigma
  • Miltenyi Biotec
  • Organicell
  • Quanterix
  • Sartorius
  • Stemcell Technologies
  • Thermo Fisher

For more information about this report visit https://www.researchandmarkets.com/r/nk3d0z

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

View source version on businesswire.com:https://www.businesswire.com/news/home/20200730005646/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD:

INDUSTRY KEYWORD: BIOTECHNOLOGY GENETICS HEALTH

SOURCE: Research and Markets

Copyright Business Wire 2020.

PUB: 07/30/2020 10:04 AM/DISC: 07/30/2020 10:04 AM

http://www.businesswire.com/news/home/20200730005646/en

Copyright Business Wire 2020.

Recommended for you

(0) comments

Welcome to the discussion.

Keep it Clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
PLEASE TURN OFF YOUR CAPS LOCK.
Don't Threaten. Threats of harming another person will not be tolerated.
Be Truthful. Don't knowingly lie about anyone or anything.
Be Nice. No racism, sexism or any sort of -ism that is degrading to another person.
Be Proactive. Use the 'Report' link on each comment to let us know of abusive posts.
Share with Us. We'd love to hear eyewitness accounts, the history behind an article.